Folks, pay attention to @jetpacks post. This is exactly how it...

Folks, pay attention to @jetpacks post. This is exactly how it works.

If you are a 708 (soph or pro) then you can access the placement terms and participate in the placement (or at least bid to). This is how you raise money fast and without the compliance nightmare and cost that accompanies a general CR that is open to non 708 investors. It's assumed that 708's know what they're doing, so they don't need the level of disclosure and protection required for a general CR.

Existing options are absolutely unaffected - the new options are unlisted (not traded on the market) so do not compete in any way with the October 20c options.

With good results from MND or canine trial/deal, all of this vitriol will be a distant memory.

And for those who seem especially vexed, a serious question: What do you say the company have done instead or this CR?

Cheers

Densy